MUTYH and cancer: Out of 15 patients, 4 (26.6%) with subsequent mature B-cell neoplasms had germline pathogenic mutations in cancer susceptibility genes; MUTYH and WRN in 2 subsequent DLBCL patients and RAD50 and LZTR1 in 2 subsequent PCM patients.